PERSPECTA

News from every angle

← Back to headlines

Needham initiates Pulse Biosciences stock with 'buy' rating

Needham has initiated coverage of Pulse Biosciences stock with a 'buy' rating, citing the company's ablation technology.

17 Aug, 11:27 — 17 Aug, 11:27
PostShare

Sources

Showing 1 of 1 sources
investing-com11h ago

Needham initiates Pulse Biosciences stock with buy on ablation tech By Investing.com - Investing.com Canada

Needham initiates Pulse Biosciences stock with buy on ablation tech By Investing.com  Investing.com Canada

Read full article →

Related Stories

This vote to sell family shares has been open since …

1h ago

Paramount Seeks $1.88 Billion Bond in Merger Lawsuit

1h ago

Russian Economist Fired After Comparing Economy to 1917; Nestle Assets Targeted

1h ago

Chelsea Chairman Boehly Considers Selling Stake to Clearlake Capital

1h ago